Gabriel Yariv
Voorzitter bij CNBX PHARMACEUTICALS INC.
Profiel
Gabriel Yariv was the founder of Instituto Simutec, founded in 2010, where he held the title of Chief Executive Officer from 2010 to 2017.
He was also the founder of The Yariv Foundation For Leadership Ltd., founded in 2006, where he held the title of Chief Executive Officer from 2006 to 2009.
Mr. Yariv's current job(s) include being the Chairman & Chief Operating Officer at CNBX Pharmaceuticals, Inc. since 2019, a Director at TaGeza Biopharmaceuticals Ltd., and a Member at Friends of The Israel Museum Society.
Mr. Yariv's education history includes undergraduate studies at Boston University.
Actieve functies van Gabriel Yariv
| Bedrijven | Functie | Begin |
|---|---|---|
| CNBX PHARMACEUTICALS INC. | Voorzitter | 05-09-2021 |
| Friends of The Israel Museum Society | Corporate Officer/Principal | - |
TaGeza Biopharmaceuticals Ltd.
 TaGeza Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TaGeza Biopharmaceuticals Ltd. develops immunotherapy and cancer-targeted pharmaceuticals. The private company is based in Tel Aviv Jaffa, Israel. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Gabriel Yariv
| Bedrijven | Functie | Einde |
|---|---|---|
| Instituto Simutec | Oprichter | 01-01-2017 |
| The Yariv Foundation For Leadership Ltd. | Algemeen Directeur | 01-01-2009 |
Opleiding van Gabriel Yariv
| Boston University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CNBX PHARMACEUTICALS INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
| Instituto Simutec | |
| Friends of The Israel Museum Society | |
| The Yariv Foundation For Leadership Ltd. | |
TaGeza Biopharmaceuticals Ltd.
TaGeza Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TaGeza Biopharmaceuticals Ltd. develops immunotherapy and cancer-targeted pharmaceuticals. The private company is based in Tel Aviv Jaffa, Israel. | Health Technology |
